There was a nice article in FNArena on the bio sector today called Return of the Living Dead II. ADO gets a mention. It also includes some statistics on the deal process between drug developer and big pharma. It will be of interest to some here.
You need to be a member to see the entire article or you can just read the original post by Fly Agaric on the ACL thread which gives a nice summary.
